Date | Acquired company | Acquiring company | Amount | Related |
---|---|---|---|---|
0000-00-00 | Vtesse (USA - MD) | Sucampo Pharmaceuticals (USA - MA) | $200 million | Rare diseases - Genetic diseases |
0000-00-00 | Universal Cells (USA - WA) | Astellas Pharma (Japan) | up to $102.5 million | Technology - Services - Regenerative Medicine |